Statins and nonalcoholic fatty liver disease: a bright future?

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.9, 2013-09, pp. : 1089-1093

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nonalcoholic fatty liver disease – current status and future directions

Journal of Digestive Diseases, Vol. 16, Iss. 10, 2015-10 ,pp. : 541-557

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nonalcoholic fatty liver disease: a review

By Poordad F Fred

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 3, 2005-08 ,pp. : 661-670

Informa Healthcare

Access to resources Recommend Favorite

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease

Current Pharmaceutical Design, Vol. 20, Iss. 14, 2014-04 ,pp. : 2403-2411

Bentham Science Publishers

Access to resources Recommend Favorite

Current treatment for nonalcoholic fatty liver disease

By Katsiki Niki Athyros Vasilios G Karagiannis Asterios Mikhailidis Dimitri P

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 2141-2142

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for non-alcoholic fatty liver disease

By Federico Alessandro Niosi Marco Vecchio Blanco Camillo Del Loguercio Carmela

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 145-158

Informa Healthcare

Access to resources Recommend Favorite